Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Prophylaxis of malaria].

M Gentilini1, E Caumes, M Danis

  • 1Département de médecine tropicale, Hôpital de la Salpêtrière, Paris.

La Revue De Medecine Interne
|May 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical relevance and prognostic impact of the classification between multibacillary and paucibacillary forms of cutaneous tuberculosis: A 24-year retrospective multicenter study.

Annales de dermatologie et de venereologie·2024
Same author

Lessons learned from treating drug-resistant TB and how to apply these to drug-susceptible TB.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2024
Same author

Klebsiella aerogenes-related facial folliculitis in men having sex with men: A hypothetical new STI?

Journal of the European Academy of Dermatology and Venereology : JEADV·2024
Same author

Patients with persistent symptoms after COVID-19 attending a multidisciplinary evaluation: Characteristics, medical conclusions, and satisfaction.

Journal of psychosomatic research·2023
Same author

Prevalence and factors associated with symptom persistence: A prospective study of 429 mild COVID-19 outpatients.

Infectious diseases now·2021
Same author

Sampling strategy for bacteriological diagnosis of intrathoracic tuberculosis.

Respiratory medicine and research·2021
Same journal

[Atypical low back pain].

La Revue de medecine interne·2026
Same journal

[Polycythemia associated chronic haemolysis].

La Revue de medecine interne·2026
Same journal

[Persistent headaches in a 55 year-old man].

La Revue de medecine interne·2026
Same journal

[Abdominal pain, fever and arthralgia in a 49-year-old woman].

La Revue de medecine interne·2026
Same journal

[Cardiorespiratory functional disorders: A transnosologic approach].

La Revue de medecine interne·2026
Same journal

[Diagnostic evaluation for suspected polycythemia].

La Revue de medecine interne·2026
See all related articles

Prevent malaria by avoiding mosquito bites and using antimalarial drugs for chemoprophylaxis. Drug choice depends on malaria resistance zones, with specific recommendations for travelers and treatment of resistant malaria.

Area of Science:

  • Tropical Medicine
  • Infectious Diseases
  • Public Health

Background:

  • Malaria prevention relies on vector control and chemoprophylaxis.
  • Mosquito bite avoidance includes individual and collective measures.
  • Chemoprophylaxis strategies vary based on geographic location and resistance patterns.

Purpose of the Study:

  • To outline malaria prevention strategies.
  • To define malaria endemic zones based on chemoresistance.
  • To provide guidance on antimalarial drug selection for travelers.

Main Methods:

  • Review of malaria prevention and treatment guidelines.
  • Classification of endemic zones by drug resistance levels.
  • Recommendations for chemoprophylaxis and treatment.

Related Experiment Videos

Main Results:

  • Three endemic zones identified by chemoresistance.
  • Key antimalarial drugs include chloroquine, proguanil, and mefloquine.
  • Mefloquine is contraindicated for pregnant women and children.

Conclusions:

  • Travelers should use antimalarials based on destination resistance and stay duration.
  • Alternative treatments are advised when mefloquine is contraindicated.
  • Quinine, halofantrine, and mefloquine are used for treating resistant malaria.